RocGene (Beijing) Technology Co., Ltd.
About Us
Be A Leader In The Field Of Molecular Diagnostics

SCROLL

Home · About Us ·
A new era of fully integrated molecular diagnostic automation

RocGene (Beijing) Technology Co., Ltd. (hereinafter referred to as Rocgene) was established in 2016 and is a bio-high-tech company founded by scientists and business people and driven by core technology. Rocgene is committed to transforming new technologies in the field of life science research into clinically relevant medical research products, and developing scientific research and molecular diagnostic products with independent intellectual property rights.


RocGene (Beijing) Technology Co., Ltd. is a wholly-owned subsidiary of Rocgene (Beijing) Scientific Instrument Co., Ltd., established in 2019, with more than 10,000 square meters of various plants and supporting facilities that meet national GMP standards. The company has three professional production lines: fluorescence quantitative PCR instrument assembly, fluorescence quantitative PCR diagnostic reagent production, and automatic nucleic acid extraction instrument assembly

Honors
Honors

National high-tech enterprise

"Specialized, special and new" small and medium-sized enterprises in Beijing

"Innovative" small and medium-sized enterprises in Beijing

Beijing intellectual property pilot unit

Zhongguancun high-tech enterprise

Medical device business license

Medical device production license

Class III medical device product registration certificate

CE-IVD certification qualification

Development History
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2016

The company was established

2017

Obtained 6 Software Copyright Registrations

Filed for Invention/Utility Model Patent: "A Real-time Quantitative Fluorescence PCR Instrument"

Designated as a "National High-tech Enterprise"

Designated as a "Zhongguancun High-tech Enterprise"

Utility Model Patent: "A Real-time Quantitative Fluorescence PCR Instrument" Approved

Launched "Archimed"—the World's First Time-Resolved Real-time Quantitative Fluorescence PCR Instrument

2018

Utility Model Patent: "A Real-Time Quantitative Fluorescence PCR Instrument" Approved

World's First "Time-Resolved Real-Time Quantitative Fluorescence PCR Instrument—Archimed" Launched

2019

PCR Instruments Enter Mass Production and Sales

Xuzhou Factory Established

2020

Participated in the Formulation of Group Standards for Food COVID-19 Nucleic Acid Testing

Contributing to the Collective Fight Against the Pandemic

CE Certification — Venturing into Overseas Markets

Archimed Mini: New Product Launch

2021

Participated in the formulation of the national standard for quantitative fluorescence PCR instruments

Successfully implemented dual factory system certifications (ISO 9001 and ISO 13485)

Instrument sales surpassed 2,000 units

Archimed X4/X6 obtained Class I Medical Device Registration Certificates

2022

Archimed Mini16 Obtains Class I Medical Device Registration Certificate

Beijing Headquarters Relocates to the Life Science Park

Designated as a "Key Enterprise" by the Changping District Government, Beijing

Production Base Expanded to 10,000 m²

Instrument Sales Surpass 10,000 Units

2023

3 Instruments Awarded Dual Certification from the U.S. FDA and UKCA

Designated a Beijing "Specialized, Refined, and Innovative" Enterprise

Relocated to the Rocgene Headquarters Building

iFIND Fully Automated Integrated Molecular POCT System Obtains Class III Medical Device Registration Certificate

2024

Wuhan Subsidiary Established

Archimed Mini Pro Obtains Class I Medical Device Registration Certificate

ArchiCycler Intelligent Gradient PCR Instrument Launched

Recognized as a "Beijing Intellectual Property Advantage Enterprise"

2025

iFIND TBR Kit Obtains Class III Medical Device Registration Certificate

Corporate Culture
  • Mission
    Committed to developing the world's leading life science research and diagnostic products
  • Purpose
    Determined to develop world-class
    core technologies Strive to be a clinical product with "technical restraint and the strongest accessibility"
  • Goal
    With life sciences and clinical research as the target market, core hardware, high-end research and applied equipment as the core, starting from the Chinese market, and aiming at the global market
Talent Acquisition
Take Control Of Your Own Destiny And Break Through The Boundaries Of Growth
Continue to Company Website
Copyright © Rocgene (Beijing) Scientific Instruments Co., Ltd. - All Rights Powered by Bomin